XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
OPERATING ACTIVITIES:              
Net income $ 19,497 $ 24,226 $ 49,915 $ 32,901 $ 47,907 $ 127,604  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization         92,527 88,803  
Deferred income tax provision         2,963 1,439  
Share-based compensation         14,350 21,994  
Amortization of debt issuance costs and expenses associated with debt refinancing         4,731 5,142  
Non-cash lease expense         2,120 3,040  
Loss (gain) on disposal of property and equipment         (4) 914  
Gain from the sale of business 0   (644)   0 (644)  
Change in fair value of contingent consideration and others         8,278 (19,481)  
Changes in assets and liabilities:              
Accounts receivable         5,050 (23,870)  
Inventories         (43,350) (24,443)  
Prepaid expenses and other current assets         (21,700) 1,629  
Other non-current assets         (8,774) 9,575  
Accounts payable, accrued expenses and other current liabilities         (22,141) (803)  
Contract liabilities         141 2,524  
Other non-current liabilities         (893) (14,288)  
Net cash provided by operating activities         81,205 179,135  
INVESTING ACTIVITIES:              
Purchases of property and equipment         (42,330) (27,887)  
Proceeds from Sale of Business         0 23,960  
Acquired in-process research and development milestone         0 (4,742)  
Net proceeds from swaps designated as net investment hedges         5,381 4,909  
Net cash used in investing activities         (36,949) (3,760)  
FINANCING ACTIVITIES:              
Proceeds from borrowings of long-term indebtedness         146,900 34,250  
Payments on debt         (85,900) (40,750)  
Payment of debt issuance costs         (7,578) 0  
Purchases of treasury stock         (275,000) (125,000)  
Proceeds from exercised stock options         4,092 1,592  
Cash taxes paid in net equity settlement         (5,549) (24,346)  
Net cash used in financing activities         (223,035) (154,254)  
Effect of exchange rate changes on cash and cash equivalents         (4,150) (22,632)  
Net decrease in cash and cash equivalents         (182,929) (1,511)  
Cash and cash equivalents at beginning of period   $ 456,661   $ 513,448 456,661 513,448 $ 513,448
Cash and cash equivalents at end of period $ 273,732   $ 511,937   $ 273,732 $ 511,937 $ 456,661